BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18296917)

  • 1. Proteasome inhibitor MG132 reverses multidrug resistance of gastric cancer through enhancing apoptosis and inhibiting P-gp.
    Zhang Y; Shi Y; Li X; Du R; Luo G; Xia L; Du W; Chen B; Zhai H; Wu K; Fan D
    Cancer Biol Ther; 2008 Apr; 7(4):540-6. PubMed ID: 18296917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone.
    Li DQ; Wang ZB; Bai J; Zhao J; Wang Y; Hu K; Du YH
    World J Gastroenterol; 2004 Jun; 10(12):1722-5. PubMed ID: 15188493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of P-glycoprotein-mediated multidrug resistance in SGC7901/VCR cells by PPARgamma activation by troglitazone.
    Chen Q; Zhou J; Jiang C; Chen J
    J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):326-31. PubMed ID: 20556576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DJ-1 overexpression confers the multidrug resistance phenotype to SGC7901 cells by upregulating P-gp and Bcl-2.
    Liu HY; Duan GL; Xu RY; Li XR; Xiao L; Zhao L; Ma ZX; Xu XW; Qiu LJ; Zhu ZM; Chen HP
    Biochem Biophys Res Commun; 2019 Oct; 519(1):73-80. PubMed ID: 31477270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.
    Zhu CY; Lv YP; Yan DF; Gao FL
    Asian Pac J Cancer Prev; 2013; 14(11):6757-60. PubMed ID: 24377601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ; Bi H; Feng JQ; Cao JG
    Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.
    Lian W; Zhang L; Yang L; Chen W
    Apoptosis; 2017 Jul; 22(7):933-941. PubMed ID: 28439677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells.
    Hao Z; Li X; Qiao T; Du R; Hong L; Fan D
    Cancer Biol Ther; 2006 Mar; 5(3):261-6. PubMed ID: 16410721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MG132 reverse the malignant characteristics of hypopharyngeal cancer.
    Ma J; Yu L; Tian J; Mu Y; Lv Z; Zou J; Li J; Wang H; Xu W
    Mol Med Rep; 2014 Jun; 9(6):2587-91. PubMed ID: 24691740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
    Tsuruo T; Naito M; Tomida A; Fujita N; Mashima T; Sakamoto H; Haga N
    Cancer Sci; 2003 Jan; 94(1):15-21. PubMed ID: 12708468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells.
    Xu SW; Law BYK; Qu SLQ; Hamdoun S; Chen J; Zhang W; Guo JR; Wu AG; Mok SWF; Zhang DW; Xia C; Sugimoto Y; Efferth T; Liu L; Wong VKW
    Pharmacol Res; 2020 Mar; 153():104660. PubMed ID: 31982489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance.
    Fujita T; Washio K; Takabatake D; Takahashi H; Yoshitomi S; Tsukuda K; Ishibe Y; Ogasawara Y; Doihara H; Shimizu N
    Int J Cancer; 2005 Nov; 117(4):670-82. PubMed ID: 15945097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K/Akt signaling pathway in ER-negative human gastric cancer cells.
    Mao Z; Zhou J; Luan J; Sheng W; Shen X; Dong X
    Biomed Pharmacother; 2014 Mar; 68(2):179-83. PubMed ID: 24184201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Pt(IV) complexes to overcome multidrug resistance in gastric cancer by targeting P-glycoprotein.
    Cao X; Li R; Xiong H; Su J; Guo C; An T; Zong H; Zhao R
    Eur J Med Chem; 2021 Oct; 221():113520. PubMed ID: 34029775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.
    Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L
    Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone reverses mitomycin C resistance in human gastric cancer cells.
    Zhang L; Hu JF; Li GQ; Xiao X; Su Q
    Am J Med Sci; 2012 May; 343(5):382-7. PubMed ID: 22052411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity.
    Gibalová L; Sedlák J; Labudová M; Barancík M; Reháková A; Breier A; Sulová Z
    Gen Physiol Biophys; 2009 Dec; 28(4):391-403. PubMed ID: 20097962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.